Instituto Valenciano de Infertilidad, IVI VALENCIA

Quick facts

Marketed products

• Agonist GnRH Acetate Triptoreline
• Agonist GnRH; estradiol Valerate; progesterone · Reproductive Medicine / Fertility
  This combination suppresses endogenous gonadotropins via GnRH agonist while providing exogenous estradiol and progesterone to support the luteal phase during assisted reproductive cycles.
• Antagonist GnRH Cetrotide · Reproductive Medicine / Fertility
  Cetrotide is a GnRH antagonist that directly blocks gonadotropin-releasing hormone receptors to suppress luteinizing hormone and follicle-stimulating hormone secretion.
• Cetrorelix and Leuprolide · Reproductive Medicine / Fertility
  Cetrorelix and leuprolide work together to suppress the pituitary-gonadal axis by blocking GnRH signaling, preventing premature luteinizing hormone surge during controlled ovarian hyperstimulation for assisted reproduction.
• COS with GnRH antagonists and HP-HMG · Reproductive Medicine / Infertility
  This protocol combines controlled ovarian stimulation (COS) with GnRH antagonists to suppress premature luteinizing hormone surge and HP-HMG (highly purified human menopausal gonadotropin) to stimulate multiple follicle development for assisted reproductive technology.
• COS with GnRH antagonists and rFSH
• Menopur®, Ferring · Reproductive Medicine / Fertility
  Menopur is a purified preparation of human menopausal gonadotropins (hMG) containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and hormone production.
• r-FSH · Reproductive/Fertility
  Recombinant follicle-stimulating hormone (r-FSH) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.
• r-FSH plus HP-hMG · Reproductive Medicine / Fertility
  A combination of recombinant follicle-stimulating hormone (r-FSH) and highly purified human menopausal gonadotropin (HP-hMG) that stimulates ovarian follicle development and hormone production for assisted reproductive technology.
• rFSH (Gonal®, · Reproductive Medicine / Infertility
  rFSH (recombinant follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.
• Tryptorelin · Oncology

Phase 3 pipeline

• FSH+LH · Reproductive Medicine / Infertility
  FSH and LH are gonadotropins that stimulate follicle development and ovulation in women, used to induce ovarian stimulation for assisted reproductive technologies.
• Ganirelix (GnRH antagonist) · Reproductive Medicine / Fertility
  Ganirelix blocks gonadotropin-releasing hormone (GnRH) receptors to suppress luteinizing hormone (LH) and prevent premature ovulation during assisted reproductive procedures.
• Provera 10 mg. · Contraception / Reproductive Health
  Provera (medroxyprogesterone acetate) is a synthetic progestin that suppresses gonadotropin secretion and inhibits ovulation by acting on the hypothalamic-pituitary-ovarian axis.
• rFSH: Follicle Stimulating Hormone · Reproductive Health
  rFSH stimulates follicular growth and maturation in the ovaries.

Phase 1 pipeline

• Folitropin Beta

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Instituto Valenciano de Infertilidad, IVI VALENCIA portfolio CI brief
• Instituto Valenciano de Infertilidad, IVI VALENCIA pipeline updates RSS